9I2O
PB2 cap-binding domain of human pathogenic influenza A virus H5N1 in complex with m7GTP
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PETRA III, DESY BEAMLINE P11 |
Synchrotron site | PETRA III, DESY |
Beamline | P11 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2024-08-04 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 1.033270 |
Spacegroup name | P 65 |
Unit cell lengths | 81.750, 81.750, 55.009 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 43.440 - 1.720 |
R-factor | 0.1846 |
Rwork | 0.182 |
R-free | 0.20590 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.008 |
RMSD bond angle | 0.794 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHENIX (1.21.2-5419_9999) |
Refinement software | PHENIX (1.21.2-5419_9999) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 43.440 | 1.820 |
High resolution limit [Å] | 1.720 | 1.720 |
Rmeas | 0.014 | |
Number of reflections | 43754 | 3589 |
<I/σ(I)> | 9.54 | |
Completeness [%] | 100.0 | |
Redundancy | 10.4 | |
CC(1/2) | 0.999 | 0.618 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 293 | The PB2 cap-binding domain (8 mg/ml) in complex with m7GTP was mixed with crystallization solution (20% w/v PEG 6000, 1 M lithium chloride, 0.1 M tri-sodium citrate at pH 4.0) at a ratio of 3:2 and incubated in a sitting drop vapor diffusion plate. |